Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
180.96
Dollar change
+2.38
Percentage change
1.33
%
IndexS&P 500 P/E21.39 EPS (ttm)8.46 Insider Own1.10% Shs Outstand51.34M Perf Week-0.64%
Market Cap9.47B Forward P/E17.39 EPS next Y10.41 Insider Trans-4.76% Shs Float51.06M Perf Month-4.55%
Income437.42M PEG6.61 EPS next Q2.42 Inst Own103.05% Short Float4.13% Perf Quarter-20.07%
Sales4.08B P/S2.32 EPS this Y-6.24% Inst Trans0.58% Short Ratio2.81 Perf Half Y-22.49%
Book/sh72.13 P/B2.51 EPS next Y4.02% ROA5.56% Short Interest2.11M Perf Year8.02%
Cash/sh3.43 P/C52.73 EPS next 5Y3.24% ROE12.54% 52W Range161.65 - 275.00 Perf YTD-23.45%
Dividend Est.- P/FCF19.44 EPS past 5Y14.84% ROI6.67% 52W High-34.20% Beta1.38
Dividend TTM- Quick Ratio1.21 Sales past 5Y12.89% Gross Margin32.72% 52W Low11.95% ATR (14)5.47
Dividend Ex-Date- Current Ratio1.58 EPS Y/Y TTM-10.29% Oper. Margin15.46% RSI (14)37.42 Volatility2.60% 2.60%
Employees21800 Debt/Eq0.76 Sales Y/Y TTM-2.41% Profit Margin10.73% Recom2.70 Target Price204.19
Option/ShortYes / Yes LT Debt/Eq0.76 EPS Q/Q-7.93% Payout0.00% Rel Volume1.11 Prev Close178.58
Sales Surprise0.17% EPS Surprise16.95% Sales Q/Q-3.19% EarningsNov 06 BMO Avg Volume750.33K Price180.96
SMA20-3.99% SMA50-6.67% SMA200-17.89% Trades Volume830,102 Change1.33%
Date Action Analyst Rating Change Price Target Change
Oct-23-24Initiated CLSA Underperform $167
Oct-14-24Initiated Redburn Atlantic Sell
Oct-07-24Downgrade Evercore ISI Outperform → In-line $225 → $190
Oct-02-24Downgrade BofA Securities Buy → Neutral $250 → $215
Oct-01-24Downgrade Citigroup Neutral → Sell $215 → $175
Aug-08-24Downgrade Robert W. Baird Outperform → Neutral $239 → $191
Aug-08-24Downgrade JP Morgan Overweight → Neutral $270 → $205
Jun-28-24Downgrade Argus Buy → Hold
Jun-07-24Initiated Mizuho Neutral $235
Jun-06-24Initiated Goldman Buy $290
Oct-30-24 10:01AM
Oct-29-24 12:10PM
Oct-21-24 07:45AM
Oct-17-24 08:00AM
Oct-16-24 04:30PM
08:00AM Loading…
Oct-03-24 08:00AM
Oct-02-24 08:00AM
Sep-17-24 08:00AM
Sep-06-24 11:31AM
10:05AM
Sep-04-24 09:21AM
Sep-03-24 04:30PM
Aug-28-24 04:46AM
Aug-19-24 06:53AM
Aug-12-24 07:01PM
09:15AM Loading…
09:15AM
Aug-09-24 01:49PM
Aug-08-24 06:30AM
01:04AM
01:03AM
Aug-07-24 08:35PM
05:36PM
04:15PM
01:30PM
01:06PM
09:30AM
08:10AM
07:07AM
07:00AM
Aug-05-24 09:16AM
07:28PM Loading…
Jul-30-24 07:28PM
08:00AM
Jul-24-24 08:43AM
08:00AM
Jul-16-24 04:30PM
Jul-09-24 09:38AM
Jul-08-24 08:00AM
Jul-05-24 09:23AM
Jun-27-24 10:23AM
Jun-26-24 07:46AM
Jun-25-24 08:00AM
Jun-18-24 08:49AM
07:53AM
04:52AM
Jun-17-24 08:00AM
Jun-11-24 08:13AM
08:00AM
Jun-06-24 08:00AM
Jun-04-24 08:00AM
Jun-03-24 08:00AM
May-31-24 10:42AM
May-30-24 08:00AM
07:17AM
May-24-24 11:38AM
May-16-24 08:06PM
May-14-24 07:02PM
May-13-24 12:15PM
09:40AM
06:55AM
May-10-24 04:06PM
08:06AM
07:22AM
06:14AM
06:08AM
01:03AM
May-09-24 11:22PM
06:13PM
12:22PM
11:57AM
09:30AM
08:18AM
07:49AM
07:34AM
07:12AM
07:00AM
May-08-24 03:29PM
06:00AM
May-06-24 09:15AM
May-02-24 08:00AM
Apr-24-24 12:47PM
Apr-22-24 08:00AM
Apr-18-24 12:09PM
Apr-16-24 11:50AM
08:00AM
Apr-12-24 08:00AM
Apr-11-24 09:10AM
08:00AM
Apr-09-24 08:00AM
Apr-04-24 08:00AM
Apr-01-24 08:00AM
Mar-27-24 08:00AM
Mar-26-24 09:39AM
Mar-23-24 09:00AM
Mar-21-24 08:00AM
Mar-15-24 11:30AM
10:30AM
Mar-14-24 09:46AM
08:00AM
Mar-12-24 08:00AM
12:11AM
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LaPlume Joseph WEVP, Corp Strategy & DevelopAug 08 '24Sale199.361,780354,86122,521Aug 12 04:13 PM
Joseph LaPlumeOfficerAug 08 '24Proposed Sale196.631,780350,000Aug 08 01:34 PM
FOSTER JAMES CChairman, President and CEOAug 01 '24Sale250.0025,0006,250,000188,251Aug 05 04:04 PM
FOSTER JAMES COfficerAug 01 '24Proposed Sale250.0025,0006,250,000Aug 01 04:07 PM
MASSARO GEORGEDirectorMay 15 '24Sale235.6233278,2255,855May 16 04:35 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopMay 10 '24Sale226.971,304295,96923,276May 14 04:49 PM
Knell Michael GunnarCSVP&Chief Accounting OfficerMar 08 '24Sale267.52808216,1567,024Mar 11 04:42 PM
Knell Michael GunnarCSVP&Chief Accounting OfficerMar 04 '24Sale261.052,750717,8907,832Mar 05 04:54 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentFeb 29 '24Sale253.453,786959,5454,792Mar 04 04:09 PM
Creamer Victoria LEVP & Chief People OfficerFeb 29 '24Sale253.705,0001,268,50013,550Mar 01 05:37 PM
Barbo William DCorporate Executive VP & CCOFeb 22 '24Sale248.504,0501,006,42522,879Feb 23 04:57 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentFeb 15 '24Option Exercise144.675,882850,9498,478Feb 20 05:32 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentFeb 15 '24Sale241.205,8821,418,7672,596Feb 20 05:32 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopFeb 15 '24Sale238.93838200,22324,620Feb 20 05:20 PM
FOSTER JAMES CChairman, President and CEOJan 29 '24Option Exercise144.6717,4362,522,466227,827Jan 31 04:59 PM
Girshick BirgitCorporate Executive VP & COOJan 10 '24Option Exercise215.195,9161,273,06450,365Jan 11 04:09 PM
Creamer Victoria LEVP & Chief People OfficerDec 14 '23Option Exercise136.705,526755,38822,032Dec 18 04:07 PM
Creamer Victoria LEVP & Chief People OfficerDec 14 '23Sale225.005,5261,243,35016,506Dec 18 04:07 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopNov 30 '23Sale197.731,850365,80023,133Dec 01 04:10 PM
Girshick BirgitCorporate Executive VP & COONov 20 '23Buy187.821,322248,29844,449Nov 21 05:07 PM
FOSTER JAMES CChairman, President and CEONov 14 '23Buy178.055,6201,000,641202,643Nov 15 09:23 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopNov 09 '23Option Exercise144.679,1281,320,54834,111Nov 13 04:12 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopNov 09 '23Sale173.489,1281,583,52224,983Nov 13 04:12 PM